Identification of novel molecular markers of mastitis caused by Staphylococcus aureus using gene expression profiling in two consecutive generations of Chinese Holstein dairy cattle

Abstract

Background

Mastitis in dairy cows caused by Staphylococcus aureus is a major problem hindering economic growth in dairy farms worldwide. It is difficult to prevent or eliminate due to its asymptomatic nature and long persistence of infection. Although transcriptomic responses of bovine mammary gland cells to pathogens that cause mastitis have been studied, the common responses of peripheral blood leukocytes to S. aureus infection across two consecutive generations of dairy cattle have not been investigated.

Methods

In the current study, RNA-Seq was used to profile the transcriptomes of peripheral blood leukocytes sampled from S. aureus-infected mothers and their S. aureus-infected daughters, and also healthy non-infected mothers and their healthy daughters. Differential gene expression was evaluated as follows: 1) S. aureus-infected cows versus healthy non-infected cows (S vs. H, which include all the mothers and daughters), 2) S. aureus-infected mothers versus healthy non-infected mothers (SM vs. HM), and 3) S. aureus-infected daughters versus healthy non-infected daughters (SMD vs. HMD).

Results

Analysis of all identified expressed genes in the four groups (SM, SMD, HM, and HMD) showed that EPOR, IL9, IFNL3, CCL26, IL26 were exclusively expressed in both the HM and HMD groups, and that they were significantly (P <  0.05) enriched for the cytokine-cytokine receptor interaction pathway. A total of 17, 13 and 10 differentially expressed genes (DEGs) (FDR P_adj. < 0.1 and |FC| > 1.2) were detected in the three comparisons, respectively. DEGs with P <  0.05 and |FC| > 2 were used for functional enrichment analyses. For the S vs. H comparison, DEGs detected included CCL20, IL13 and MMP3, which are associated with the IL-17 signaling pathway. In the SM vs. HM and SMD vs. HMD comparisons, five (BLA-DQB, C1R, C2, FCGR1A, and KRT10) and six (BLA-DQB, C3AR1, CFI, FCAR, FCGR3A, and LOC10498484) genes, respectively, were involved in the S. aureus infection pathway.

Conclusions

Our study provides insights into the transcriptomic responses of bovine peripheral blood leukocytes across two generations of cattle naturally infected with S. aureus. The genes highlighted in this study could serve as expression biomarkers for mastitis and may also contain sequence variation that can be used for genetic improvement of dairy cattle for resilience to mastitis.

Background

Bovine mastitis is an inflammation-driven disease of the mammary gland in cows. It normally occurs in response to infection by one of a number of pathogenic microorganisms including Escherichia coli and Staphylococcus aureus [1, 2]. It is widely recognized that the high incidence of bovine mastitis, coupled with associated animal welfare problems and the use of antimicrobials, means that this disease is one of the major challenges facing the dairy industry in the twenty-first century [3]. S. aureus is an important type of Gram-positive bacteria and is defined as a “contagious pathogen” [4]. S. aureus can adapt to the mammary gland environment and establish subclinical infections [1, 5]. The symptoms of S. aureus mastitis are usually less severe than mastitis caused by infection with E. coli, and may even be asymptomatic; however, the infection can persist for long periods and can also exhibit marked resistance to antibiotics [6]. S. aureus typically spreads among cattle within dairy herds during the process of milking [7], making prevention, control and elimination particularly difficult. Therefore, bovine mastitis caused by this bacterial pathogen represents a substantial economic burden to dairy production and also poses a significant public health risk through milk consumption.

Global functional genomics technologies, such as RNA sequencing (RNA-Seq), which is enabled by high-throughput sequencing (HTS), are ideally suited for investigating the complex host-pathogen interaction underlying mastitis disease caused by S. aureus infection and may also provide relevant data for elucidating the molecular mechanisms associated with resilience to mastitis disease. RNA-Seq enables expression quantification analysis of thousands of genes simultaneously [6, 8], thereby facilitating identification of individual genes that exhibit the largest expression changes in response to a biological perturbation such as infection by a bacterial pathogen. Several transcriptomics studies have investigated the bovine mammary gland tissue response to S. aureus [9] and E. coli [10], and also the hepatic tissue response to E. coli infection and lipopolysaccharide (LPS) challenge [11, 12]. However, to-date, no studies have been carried out on the peripheral blood transcriptome for S. aureus infection in cows and their offspring simultaneously.

In the current study, using RNA-Seq, we characterized the transcriptomes of peripheral blood leukocyte (PBL) samples collected from S. aureus-positive mother-daughter pairs and S. aureus-negative control mother-daughter pairs. The main objective of this work was to identify candidate blood-based transcriptional biomarkers for bovine mastitis caused by S. aureus and to provide new insights into host-pathogen interaction and the genetics of disease resistance.

Methods

Animal selection and sampling

All procedures for collection of animal blood and milk samples were approved by the Animal Welfare Committee of China Agricultural University, Beijing, China. All experiments were conducted according to the regulations and guidelines established by this committee (permit number: DK996).

In the present study, a lactating dairy cow and her lactating mother were defined as a mother-daughter pair. A total of 38 mother-daughter pairs were selected based on pedigree information and somatic cell counts (SCC) from a lactating herd of Holstein cows (n ≈ 1,200) at a dairy farm near Beijing, China. The SCC data for three consecutive months were measured and recorded. The Dairy herd improvement (DHI) records were provided by the Dairy Data Centre of China (www.holstein.org.cn). For the present study, milk SCC values of less than 100,000 cells/mL from both mothers and daughters were considered to be healthy [13]. Conversely, SCC values larger than 100,000 cells/mL were considered for diagnosis of subclinical mastitis. Detailed information on cow selection is provided in Fig. 1a and Table 1.

Fig. 1.

Identification of S. aureus isolated from milk samples from Holstein cows. a Workflow of sample selection. A total of 38 mother-daughter pairs were selected from 1,200 lactating dairy cattle according to pedigree and SCC records. After S. aureus identification from milk samples, four S. aureus-positive and four S. aureus-negative pairs were used for subsequent studies. b Specific PCR and electrophoresis map of the S. aureus thermonuclease (nuc) gene (279 bp). SA: abbreviation of S. aureus. +: S. aureus-positive control; −: S. aureus-negative control. SM: S. aureus mastitis mother; HM: healthy mother; SMD: S. aureus mastitis daughter; HMD: healthy daughter. c Sequence alignment of partial nuc gene. The upper lines were amplified from samples collected from the cows’ milk; the lower line is nuc sequence amplified from one of the S. aureus-positive samples. Identity = 95.68%

Table 1.

Basic information and bacterial culture of the 16 Chinese Holstein milk samples

Sample	Age	Days of lactation	SCC × 1000/mL			SCS			MY			FP			PP			Bacterium
			−3 months	−2 months	− 1 month	−3 months	−2 months	−1 month	−3 months	−2 months	−1 month	−3 months	−2 months	−1 month	−3 months	−2 months	−1 month
SM1	8	482	561.00	911.00	1071.00	5.49	6.19	6.42	28.80	28.60	26.80	3.93	4.06	4.28	3.63	3.75	3.65	S. aureus
SM2	5	266	972.00	4641.00	4289.00	6.28	8.54	8.42	31.00	42.60	34.40	3.79	2.75	3.59	3.49	2.65	3.02	S. aureus
SM3	8	529	382.00	1076.00	852.00	4.93	6.43	6.09	36.70	37.50	35.80	2.14	3.97	4.10	3.38	2.98	2.91	S. aureus
SM4	5	291	155.00	585.00	241.00	3.63	5.55	4.27	31.30	31.30	24.60	2.10	3.81	3.52	3.42	3.29	3.30	S. aureus
Mean ± SD			517.5 ± 149.63	1803.25 ± 823.94	1613.25 ± 787.25	5.08 ± 0.48	6.67 ± 0.56	6.30 ± 0.74	31.95 ± 1.45	35 ± 2.72	30.4 ± 2.39	2.99 ± 0.44	3.65 ± 0.26	3.87 ± 0.16	3.48 ± 0.05	3.17 ± 0.20	3.22 ± 0.14
SMD1	6	171	207.00	596.00	2249.00	4.05	5.58	7.49	58.00	50.90	41.60	3.67	3.46	3.51	2.96	3.11	3.24	S. aureus
SMD2	3	299	116.00	121.00	202.00	3.21	3.28	4.01	42.70	37.70	35.60	3.84	3.60	4.15	3.03	3.05	3.13	S. aureus
SMD3	3	125	283.00	102.00	64.00	2.99	1.49	2.96	25.70	25.50	24.70	2.76	3.26	2.85	3.31	3.06	3.32	S. aureus
SMD4	2	33	99.00	113.00	145.00	2.99	3.18	3.54	31.30	38.60	37.70	2.89	4.95	1.73	2.83	2.86	2.88	S. aureus
Mean ± SD			176.25 ± 37.03	233 ± 104.84	665 ± 457.92	3.31 ± 0.22	3.38 ± 0.73	4.50 ± 0.88	39.43 ± 6.18	38.18 ± 4.49	34.9 ± 3.14	3.29 ± 0.24	3.82 ± 0.33	3.06 ± 0.45	3.03 ± 0.088	3.02 ± 0.05	3.14 ± 0.08
HM1	7	258	101.00	155.00	73.00	3.01	3.63	2.55	51.80	47.40	38.00	2.78	3.02	2.88	3.06	2.97	2.92	–
HM2	6	222	28.00	37.00	57.00	1.16	1.57	2.19	38.10	35.30	30.10	3.82	4.40	3.89	3.12	3.17	3.13	–
HM3	5	173	76.00	23.00	39.00	2.60	0.88	1.64	58.30	58.80	56.00	3.78	3.81	3.46	3.34	3.22	3.23	–
HM4	5	244	153.00	34.00	44.00	3.61	1.44	1.82	42.10	40.80	38.20	4.69	4.31	3.95	3.88	3.25	3.12	–
Mean ± SD			89.5 ± 22.54	62.25 ± 26.90	53.25 ± 6.58	2.60 ± 0.45	1.88 ± 0.52	2.05 ± 0.17	47.58 ± 3.97	45.58 ± 4.38	40.58 ± 4.74	3.77 ± 0.34	3.89 ± 0.27	3.55 ± 0.21	3.35 ± 0.16	3.15 ± 0.05	3.1 ± 0.06
HMD1	3	145	22.00	19.00	27.00	0.82	0.60	1.11	35.70	40.30	38.80	3.91	3.66	3.53	3.01	3.18	3.08	–
HMD2	4	212	22.00	32.00	514.00	0.82	1.36	5.36	52.00	46.30	25.10	3.42	2.57	5.11	3.27	3.32	3.46	–
HMD3	3	271	60.00	20.00	61.00	2.26	0.68	2.29	42.90	42.70	35.80	3.31	3.30	2.60	3.17	3.14	3.18	–
HMD4	3	250	30.00	61.00	47.00	1.26	2.29	1.91	37.30	42.20	36.60	3.48	3.76	4.33	3.11	3.22	3.18	–
Mean ± SD			33.5 ± 7.82	33 ± 8.48	162.25 ± 101.72	1.29 ± 0.30	1.23 ± 0.34	2.67 ± 0.81	41.98 ± 3.19	42.88 ± 1.09	34.08 ± 2.65	3.53 ± 0.11	3.32 ± 0.23	3.89 ± 0.47	3.14 ± 0.047	3.22 ± 0.03	3.23 ± 0.07

Note: SM- S. aureus infected mastitis mothers; SMD- S. aureus infected daughters; HM- Healthy mothers; HMD- Healthy daughters; the four SMD animals were the descendants of the four SM animals, respectively; the four HMD animals were the descendants of the four HM animals, respectively; except HMD1 and HMD3 are half-siblings of one sire, the other animals are descendants of different sires; SCC: Somatic cell counts per milliliter of milk sample; SCS = log₂(SCC/100,000) + 3; MY: milk yield, FP: milk fat percentage; PP: milk protein percentage; −indicates samples without S. aureus infection

For S. aureus identification, a total of 30 mL of fresh milk was collected and mixed from all of the four lactating quarters of each cow. Subsequently, based on the bacteriological culture and PCR results, four S. aureus-positive mother-daughter pairs were selected and separated into the S. aureus mother group (SM, n = 4) and the S. aureus daughter group (SMD, n = 4). Similarly, four S. aureus-negative mother-daughter pairs were separated into the healthy mother group (HM, n = 4) and the healthy daughter group (HMD, n = 4) (Fig. 1a).

S. aureus isolation and identification

Bacteriological culture of milk samples was carried out according to National Mastitis Council standards [14]. A volume of 3 mL milk was mixed into trypticase soy broth containing 7.5% NaCl and cultured at 37 °C for 18–24 h. After that, a total of 10 mL culture was placed into Baird-Parker agar plates with tellurite and 5% egg yolk and cultured at 37 °C for 18–24 h. Two suspected colonies from each sample with surrounding clear zones were transferred to trypticase soy agar plated for DNA collection. Following this step, PCR amplification and sequencing of the S. aureus thermonuclease gene (nuc) [15] was performed (Fig. 1b and c). The PCR reaction was performed in 25 μL, containing 3 μL of genomic DNA (30–50 ng/μL), 1 μL of each primer (10 μmol), 12.5 μL of Taq™ Mix (1.25 units/25 μL reaction) and 7.5 μL of ddH₂O. PCR was performed using the following thermocycler program: 94 °C for 10 min; 35 cycles of 94 °C for 30 s, 59 °C for 30 s and 72 °C for 30 s; 72 °C for 7 min.

Blood collection, RNA extraction and RNA-sequencing

A 20-mL blood sample was obtained from the caudal vein from each animal for buffy coat (leukocytes) collection using 15 min centrifugation at 3,000 r/min.

TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used to isolate total RNA from leukocytes according to the manufacturer’s protocol. The RNA quality was checked on a 1% agarose gel and quantified using a Qubit RNA Assay Kit and a Qubit 2.0 Fluorometer (ThermoFisher Scientific, Waltham, MA USA). RNA integrity was assessed with the BioAnalyzer 2100 System (Agilent Technologies, Santa Clara, CA, USA). All 16 RNA samples had an RNA integrity number (RIN) larger than 7.0 (Supplementary Table S1). The 28S:18S rRNA ratios of all samples were larger than 1.7 (Supplementary Table S1). An equivalent amount (4 μg) of total PBL RNA purified from each animal was used to construct RNA-Seq libraries with the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB, Ipswich, MA, USA). Finally, the libraries were sequenced using 150 bp paired-end reads with the Illumina HiSeq X Ten System (CapitalBio Technology, Beijing, China).

Quality control for raw data

Trimmomatic software version 0.38 [16] was used to filter out the adapter sequence and low-quality bases/reads with the default parameters (http://www.usadellab.org/cms/?page=trimmomatic). Further quality assessment of the sequence reads was then undertaken using FastQC version 0.11.8 [17]. After these QC procedures were completed, the sequence read data were used for the downstream analyses in the computational workflow.

Reads alignment and abundance estimation

The Bos taurus ARS-UCD1.2 reference assembly (FASTA format) and annotated gene model (GTF format) were downloaded from the Ensembl database (ftp.ensemble.org/pub/release-96/gtf/bos_taurus). The QC-assessed sequence read data for each sample were aligned to the reference genome using STAR with the basic options [18]. Transcript abundance was quantified using featureCounts [19] in the R subread package [20] under the default setting, and read counts were calculated to estimate the transcript expression levels. Genes with read counts more than ten in at least two samples were defined as expressed genes. The rlog-normalized read count was calculated with DESeq2 [21], which was then used to performed differential expression analysis.

The transcriptional responses to S. aureus infection were investigated by comparing differentially expressed genes between the infected and non-infected healthy control groups. We firstly analyzed gene expression levels in the S group (n = 8, 4 animals each in the SM and SMD groups) and H group (n = 8, 4 animals each in the HM and HMD groups), and compared the differentially expressed genes (DEGs) between the two groups. Detection of DEGs was also performed for the comparisons of the mother groups (SM vs. HM) and the daughter groups (SMD vs. HMD).

Functional enrichment and annotation

Gene set enrichment analysis was performed for all the expressed genes detected between the S and H groups, using the GSEA software package (v4.0.3) with the Human NCBI Gene ID Molecular Signature Database (MSigDB) version 7.0 and Hallmark database version 7.0 [22–24]. Gene sets were considered significant when P <  0.05 and FDR <  0.25 [25, 26].

The DEGs (P <  0.05 and |FC| > 2) in the comparisons of S vs. H, SM vs. HM and SMD vs. HMD were used to perform the following functional enrichment analysis. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) enrichment analyses of gene clusters were performed using clusterProfiler [27], with results exhibiting P <  0.05 considered significant. An interaction network analysis was also conducted using Ingenuity Pathway Analysis (IPA; Qiagen, Redwood City, CA, USA) [28].

Validation of RNA-Seq results through reverse transcription quantitative real-time PCR (RT-qPCR)

To quantitatively assess the reliability of our sequencing data, the expression levels of seven (SM vs. HM comparison) and ten (SMD vs. HMD comparison) randomly selected genes were estimated with RT-qPCR in the same samples used for RNA-Seq (Supplementary Table S1). The RNA samples were reverse transcribed into cDNA using the PrimeScript™ RT reagent kit according to the manufacturer’s instructions (Takara Bio, Dalian, China). Real-time detection of specific PCR products was performed with the Sybr Green I Master Mix Kit (Roche Diagnostics, Mannheim, Germany) on the LightCycler 480 II (Roche Diagnostics Ltd., Basel, Swetzerland), according to the manufacturer’s protocol. The oligonucleotide primers used for the RT-qPCR analysis are provided in Supplementary Table S2. The thermocycler program used was as follows: one cycle of preincubation at 95 °C for 10 min, 45 cycles of amplification (95 °C for 10 s, 60 °C for 10 s, and 72 °C for 10 s). Duplicate RT-qPCR assays were performed on each cDNA sample and relative expression values were calculated using the 2^–△△Ct method with the bovine glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) as the internal reference [29, 30]. The log₂|FC| values were calculated from RT-qPCR data to directly compare to the RNA-Seq results.

Statistical analysis

A linear regression analysis was conducted using the Prism software package (version 8; GraphPad Software, San Diego, CA, USA) to evaluate gene expression levels among experimental groups. For RT-qPCR data, the significant differences between groups were examined with the Student’s t-test.

Results

Transcriptomic data and detection of expressed genes in peripheral blood leukocyte samples

In the present study, an average of 22,435,225 (ranging from 18,801,274 to 25,620,906) paired-end reads were generated as raw data from the 16 RNA-Seq libraries. After filtering, an average of 20,955,429 reads (ranging from 16,864,277 to 23,829,973) were retained for each library. The average uniquely mapping rate was 94.11% (Supplementary Table S3). There were 10,287 detectable genes expressed in both the SM and SMD groups, and 10,248 gene expressed in the HM and HMD groups (Fig. 2a). A total of 10,086 detectable expressed genes were shared across the four groups. A total of 201 genes were identified that were exclusively expressed in the two consecutive generations of animals naturally infected with S. aureus (SM and SMD), which may be associated with susceptibility to S. aureus-induced mastitis. Conversely, 162 genes were exclusively expressed in the two consecutive generations of healthy control animals (HM and HMD), which may be associated with resilience to S. aureus-induced mastitis.

Fig. 2.

Comparison of gene expression profiles between mothers and daughters. a Venn diagram showing genes only expressed in S. aureus-positive mother-daughter pairs (purple circle), genes only expressed in S. aureus-negative mother-daughter pairs (yellow circle), and genes in intersection are common to both groups. b Linear regression analysis of expression levels for 201 genes exclusively expressed in the SM and SMD groups. c Linear regression analysis of expression levels for 162 genes exclusively expressed in the HM and HMD groups. d Significantly enriched (P < 0.05) KEGG pathways of genes exclusively expressed in the S. aureus-positive groups (SM and SMD). e Significantly enriched (P < 0.05) KEGG pathways of genes exclusively expressed in the S. aureus-negative groups (HM and HMD)

Furthermore, the correlation between the gene expression profiles (log₂|FC| of 4000 randomly selected genes) in the two generations of SM vs. HM and SMD vs. HMD was significant (R² = 0.3410, P < 0.0001, Supplementary Fig. S1). This result indicates that gene expression changes due to S. aureus infection challenge were moderately conserved between the two generations. The linear regression analyses were also performed using the normalized read counts of the 201 exclusively expressed genes (R² = 0.9991, P < 0.0001, Fig. 2b) in the two generations of animals naturally infected with S. aureus (SM and SMD) and the 162 exclusively expressed genes (R² = 0.9921, P < 0.0001, Fig. 2c) in the two generations of healthy controls (HM and HMD).

Transcriptome changes in peripheral blood leukocytes from S. aureus-positive cattle compared to S. aureus-negative control cattle

It is well established that S. aureus, as an intracellular pathogen of mammals, has evolved a wide range of mechanisms for immunosuppression and immunoreaction [31, 32]. To investigate host-pathogen interaction in bovine PBL infected with S. aureus, the transcriptomes of infected cattle and non-infected healthy control animals were compared. Although no significant DEGs were detected using an FDR P_adj. threshold of 0.05, a total of 17, 13 and 10 DEGs were observed for the three comparisons (Table 2, 3 and 4), respectively, using the criteria of FDR P_adj. < 0.1 and |FC| > 1.2 [33–35]. Furthermore, a total of 301, 283 and 260 DEGs (P < 0.05, log₂|FC| > 2) (Supplementary Table S5, 6 and 7 and Fig. S2) were used for functional enrichment analysis. The expression heat maps of the 301, 283 and 260 genes of the three comparisons revealed different transcriptional profiles between S. aureus-positive and S. aureus-negative samples (Fig. 3). To validate the RNA-Seq results, seven and ten genes were selected for RT-qPCR validation in the SM vs. HM and SMD vs. HMD comparisons (Fig. 4), respectively. Results from this analysis showed that the gene expression patterns obtained using RNA-Seq were consistent with the results generated from RT-qPCR (Fig. 4a and c). The correlation coefficients between the RNA-Seq and RT-qPCR results for the genes in the SM vs. HM and SMD vs. HMD comparisons were 0.97 and 0.90 (P < 0.0001), respectively (Fig. 4b and d).

Table 2.

Differentially expressed genes in the S vs. H comparison (FDR P_adj. < 0.1 with |FC| > 1.2)

Ensembl ID	Gene symbol	Genome position	Log2 fold change	P-value	Padj.
ENSBTAG00000006859	CEACAM6	18:51400717–51406445	−1.5900	4.67E-10	8.06E-06
ENSBTAG00000037452	LOC790312	10:26644523–26648616	−2.8690	1.16E-07	0.0010
ENSBTAG00000043548	–	MT:364–430	3.3845	3.37E-06	0.0194
ENSBTAG00000005078	UCHL1	6:60147025–60159287	1.1728	5.91E-06	0.0255
ENSBTAG00000017786	FCRL6	3:9870119–9891157	2.1591	8.41E-06	0.0290
ENSBTAG00000048420	–	18:62937680–62942083	− 1.6206	1.24E-05	0.0340
ENSBTAG00000017038	HPS4	17:66113220–66140520	−0.5173	1.38E-05	0.0340
ENSBTAG00000018596	PTPN21	10:100170718–100247414	−1.488	1.59E-05	0.0344
ENSBTAG00000047621	–	16:5146970–5149550	0.9748	1.84E-05	0.0352
ENSBTAG00000045507	ZNF469	18:13698486–13709861	−1.5298	4.01E-05	0.0691
ENSBTAG00000005725	IDO2	27:35048477–35114325	1.6464	5.64E-05	0.0886
ENSBTAG00000013281	SPATA21	2:135698556–135736414	−0.6353	6.17E-05	0.0887
ENSBTAG00000019455	MYO5B	24:49490278–49824858	−1.1553	7.22E-05	0.0958
ENSBTAG00000011554	SURF6	11:104240172–104246931	−0.4955	8.39E-05	0.0997
ENSBTAG00000053500	–	5:74430343–74435609	−1.0656	9.18E-05	0.0997
ENSBTAG00000049399	–	4:82745643–82745786	1.2984	9.35E-05	0.0997
ENSBTAG00000035945	–	4:50056455–50082481	1.0603	9.82E-05	0.0997

Table 3.

Differentially expressed genes in the SM vs. HM comparison (FDR P_adj. < 0.1 and |FC| > 1.2)

Ensembl ID	Gene symbol	Genome position	Log2 fold change	P-value	Padj.
ENSBTAG00000006859	CEACAM6	18:51400717–51406445	−2.1830	3.54E-10	5.26E-06
ENSBTAG00000015405	DCHS1	15:46407409–46444149	1.1298	8.23E-08	0.0006
ENSBTAG00000039046	CD24	2:117785379–117787180	−1.3277	6.26E-06	0.0311
ENSBTAG00000018077	LYPD3	18:51674245–51678673	1.4669	1.53E-05	0.0568
ENSBTAG00000035945	–	4:50056455–50082481	1.5454	2.57E-05	0.0723
ENSBTAG00000054978	–	4:99079895–99088132	1.1172	3.14E-05	0.0723
ENSBTAG00000015061	–	18:61209482–61224598	2.2668	3.40E-05	0.0723
ENSBTAG00000000507	NR4A1	5:27820352–27839685	−0.8279	4.84E-05	0.0843
ENSBTAG00000053508	–	21:312642–314960	−2.6172	5.30E-05	0.0843
ENSBTAG00000017786	FCRL6	3:9870119–9891157	2.9479	5.67E-05	0.0843
ENSBTAG00000053424	–	7:5751646–5755931	−2.1134	6.96E-05	0.0942
ENSBTAG00000047302	–	13:67292055–67307842	2.3906	7.65E-05	0.0949
ENSBTAG00000046383	–	18:62453964–62454894	−2.0405	8.60E-05	0.0984

Table 4.

Differentially expressed genes in the SMD vs. HMD comparison (FDR P_adj. < 0.1 and |FC| > 1.2)

Ensembl ID	Gene symbol	Genome position	Log2 fold change	P-value	Padj.
ENSBTAG00000037452	LOC790312	10:26644523–26648616	−3.2530	5.89E-07	0.0066
ENSBTAG00000043250	7SK	23:25224255–25224585	4.4505	7.57E-07	0.0066
ENSBTAG00000053635	–	21:394145–395961	−2.0210	2.72E-06	0.0158
ENSBTAG00000019741	C3AR1	5:101566575–101575901	2.4457	5.54E-06	0.0242
ENSBTAG00000006582	SSTR1	21:48348493–48351072	−3.1215	9.41E-06	0.0300
ENSBTAG00000039440	–	19:20556890–20557410	5.8616	1.03E-05	0.0300
ENSBTAG00000019455	MYO5B	24:49490278–49824858	−1.4318	1.92E-05	0.0480
ENSBTAG00000048135	–	20:71927027–71928602	−1.5261	2.76E-05	0.0603
ENSBTAG00000050180	Metazoa_SRP	10:42834493–42834792	5.9138	3.30E-05	0.0641
ENSBTAG00000008103	ALDH1A1	8:49053228–49106706	3.0839	3.70E-05	0.0646

Fig. 3.

Transcriptomic changes of PBL in the three comparisons. Cluster analyses and heat maps of DEGs in (a) S vs. H, (b) SM vs. HM and (c) SMD vs. HMD. The different columns represent different samples and the different rows denote different DEGs. Red and blue show increased and decreased expression, respectively

Fig. 4.

RT-qPCR validation of RNA-Seq results. a and c RT-qPCR confirmation results for the randomly selected DEGs from the SM vs. HM comparison and the SMD vs. HMD comparison, respectively. b and d Regression analysis of the log₂|FC| values between the RNA-Seq and RT-qPCR validation of the SM vs. HM and the SMD vs. HMD comparisons, respectively. The GAPDH gene was used as an internal reference control gene. * means P < 0.05. ** means P < 0.01

Functional enrichment and annotation

The GSEA analysis performed between S and H groups revealed that a total of 38 gene sets were upregulated in S group compared to the controls, of which six gene sets were significant at FDR < 0.25 and P < 0.05. Significantly enriched gene sets (FDR < 0.25 and P < 0.05) in the S group are shown in Supplementary Fig. S3 and the enrichment information is summarized in Supplementary Table S4.

KEGG pathway analysis of 201 genes exclusively expressed in S. aureus-positive animals revealed nine significantly enriched KEGG pathways (P < 0.05) (Fig. 2d). Whereas genes exclusively expressed in S. aureus-negative animals revealed four significantly enriched KEGG pathways (P < 0.05) (Fig. 2e). Five genes (EPOR, IL9, IFNL3, CCL26, and IL26) exclusively expressed in S. aureus-negative animals were enriched in the cytokine-cytokine receptor interaction KEGG pathway.

KEGG pathway analysis of the 301 DEGs in the S vs. H comparison revealed 15 significant enriched pathways (P < 0.05) (Fig. 5a). Most of these pathways were associated with the immune response or inflammation. For example, the IL-17 signaling pathway was enriched by three DEGs (CCL20, IL13, and MMP3). Furthermore, ten KEGG pathways were significantly enriched (P < 0.05) by DEGs in the SM vs. HM comparison and, among these, S. aureus infection was the most significantly enriched pathway (Fig. 5b). Moreover, DEGs in the comparison of SMD vs. HMD were significantly (P < 0.05) enriched in ten pathways, including S. aureus infection, phagosome. Importantly, six DEGs were significantly involved in the S. aureus infection pathway (Fig. 5c). The top ten biological processes identified using GO enrichment analysis are shown in Supplementary Fig. S4.

Fig. 5.

KEGG pathway enrichment of DEGs. a KEGG pathways of DEGs in the comparison of S vs. H and expression differences of the DEGs involved in the enrichment of the IL-17 signaling pathway. b KEGG pathways of DEGs in the comparison of SM vs. HM and expression differences of the DEGs involved in the enrichment of the S. aureus infection pathway. c KEGG pathways of DEGs in the comparison of SMD vs. HMD and expression differences of the DEGs involved in the enrichment of the S. aureus infection pathway

To construct interaction networks, the DEGs in each comparison were further analyzed using the IPA software tool. Interestingly, the PI3K family is shared across all networks generated for the three comparisons and interacted with 13, 6 and 11 molecules in comparisons of S vs. H, SM vs. HM and SMD vs. HMD, respectively (Figs. 6, 7 and 8). Moreover, the IL12 complex and kinase AKT both play key roles in the SM vs. HM and SMD vs. HMD comparison (Figs. 7 and 8). Collectively, these functional analysis results suggested that the immune responses were activated in PBL from S. aureus-infected dairy cattle.

Fig. 6.

IPA interaction network generated from the DEG list in the S vs. H comparison. Red denotes gene nodes that were increased in expression, and green denotes nodes that were decreased in expression in S samples compared to H samples. The red circle denotes a commonly shared node in the three comparisons

Fig. 7.

IPA interaction network generated from the DEG list in the SM vs. HM comparison. Red denotes gene nodes that were increased in expression, and green denotes nodes that were decreased in expression in SM samples compared to HM samples. The red circle denotes a commonly shared node in the three comparisons

Fig. 8.

IPA interaction network generated from the DEG list in the SMD vs. HMD comparison. Red denotes gene nodes that were increased in expression, and green denotes nodes that were decreased in expression in SMD samples than HMD samples. The red circle denotes a commonly shared node in the three comparisons

Finally, the linear regression results between normalized read counts and SCC showed that significant correlations were observed between the expression levels of DEGs (CXCL9, SOCS1, LOC508858, and CYP2E1) and SCC (Fig. 9), suggesting these genes might be served as potential molecular biomarkers of mastitis caused by infection with S. aureus.

Fig. 9.

Linear regression analysis between normalized read counts and SCC. The X-axis indicates normalized read counts of DEGs, and the Y-axis indicates SCC. a-d) represent CXCL9, SOCS1, LOC508858, and CYP2E1, respectively

Discussion

In recent years, health traits, including mastitis resistance, are increasingly being incorporated into the breeding goals of the modern dairy industry [36–38]. Mastitis is a low heritability trait [39, 40] and it is therefore difficult to achieve significant improvements using conventional breeding strategies. Therefore, it is important to investigate the complex host-pathogen interaction underlying mastitis disease caused by S. aureus infection from the perspective of the peripheral blood transcriptome. In previous genome-wide association studies (GWAS), a number of candidate genes (TRAPPC9 [41], mTORC1 [42], JAK2 and STAT5A [43]) were observed to be associated with mastitis-related traits such as SCC. However, transcriptome profiles of S. aureus infection in both cows and their offspring have not been studied in detail. In the current study, for the first time, transcriptome profiles of PBL in response to S. aureus infection were investigated in two generations of dairy cattle.

Previous studies have identified many genes as potential expression biomarkers for bovine mastitis caused by infection with S. aureus mastitis [6, 44]. However, the concordance among these results is not high, possibly as a consequence of environmental factors and varying genetic backgrounds. To address this issue, eight mother-daughter pairs (four S. aureus-infected pairs and four uninfected mother-daughter pairs) from the same farm were used as experimental subjects for the current study. Three well-defined animal selection criteria were used for comparative analyses of the transcriptomes of PBL sampled from two generations of dairy cattle infected with S. aureus-induced mastitis: 1) availability of mother-daughter pairs, 2) three consecutive months of SCC score recordings, and 3) unambiguous S. aureus detection and identification.

For dairy cattle, to produce 1 kg of milk, 400 to 500 kg of blood must pass through the udder [45]. Consequently, PBL represents a valuable sample resource to evaluate the condition of udder health. In our previous study [44], we infected udder quarters with S. aureus (1 × 10⁶ CFU/mL), then conducted mammary biopsies, and collected udder tissues for RNA extraction and transcriptome analysis using RNA-Seq. Mammary biopsies cause trauma and stress; therefore, the use of an accessible and informative tissue such as peripheral blood from naturally infected animals in a production population substantially mitigates animal welfare issues. Thus, PBL samples from two generations of S. aureus-infected cows were used to perform transcriptome sequencing.

Our study is the first to describe transcriptomic profiles of PBL in S. aureus-infected and uninfected dairy cattle across two generations. More than 160 genes were observed solely in the healthy mother-daughter pairs compared to the S. aureus-infected mother-daughter pairs, an observation that may be relevant to identification of genes underpinning resilience to S. aureus mastitis (Fig. 2a). These genes were observed to be significantly enriched in four biological pathways with the cytokine-cytokine receptor interaction pathway directly related to the immune response. Five genes (EPOR, IL9, IFNL3, CCL26, and IL26) that were involved in this pathway might serve as potential molecular markers for breeding programs that enhance resistance to S. aureus infection and mastitis (Fig. 2e). Thus, these immune-related genes warrant further study in a larger group of animals across two generations.

EPOR encodes the erythropoietin receptor, which is a member of the cytokine receptor family. It can activate JAK2 tyrosine kinase that, in turn, activates a range of intracellular pathways. A previous study observed that the IL9 gene emerged as a central node in the network associated with Streptococcus agalactiae-induced subclinical mastitis [46]. In this regard, we have also identified IL9 as a key gene associated with S. aureus-induced subclinical mastitis. Interestingly, sequence variation at IFNL3 has been shown to be associated with hepatitis B virus (HBV) infection in a Chinese human population [47]. CCL26 encodes a secreted protein involved in immunoregulatory and inflammatory processes, which Anna et al. observed to be associated with IL4-mediated signaling pathways in bovine macrophages challenged in vitro with S. agalactiae [48]. The protein encoded by IL26 is a member of the IL10 family of cytokines [49], which has been shown to exhibit anti-bacterial activity against a wide range of bacteria including S. aureus [50], suggesting a broader role in host defenses against bacteria [51].

As expected, a small number of DEGs (Fig. 3) were detected using FDR P_adj. < 0.1, a less stringent statistical threshold. Chinese dairy cattle represent a relatively outbred animal population with significant variation in genetic background [52]. S. aureus can readily adapt to its host through evasion of almost every facet of the immune system [32]; therefore, S. aureus-infected cows may exhibit less severe and milder immune responses, which may account for the relatively small number of DEGs. In this regard, Fang et al. also reported modest differential gene expression in bovine mammary gland induced by a low dose of S. aureus to simulate naturally infected mastitis [44]. It would therefore be instructive to perform a substantially larger in vitro challenge experiment using varying S. aureus challenge doses.

Indoleamine 2,3-dioxygenase 2 encoded by IDO2 is an immunomodulatory molecule with potential effects on various diseases including cancer and autoimmune conditions. A previous study demonstrated that IDO2 functions as a modifier in B cells to control pathogenic inflammation and autoimmunity [53]. NR4A1, which encodes the nuclear receptor subfamily 4 group A member 1 protein, was differentially expressed in the comparison of SM vs. HM for the current study. NR4A1 has been shown to play a key role as a regulator of the immune response to apoptotic cells [54].

In the present study, immune-related pathways were enriched by different but complementary functional enrichment and annotation methods (KEGG, IPA and GSEA). Three DEGs (CCL20, IL13, and MMP3) were found to be involved in the IL-17 signaling pathway in the S vs. H comparison (Fig. 5a). The interleukin 17 (IL-17) family are proinflammatory cytokines that play crucial roles in both acute and chronic inflammatory responses [55]. Moreover, there are five (BLA-DQB, C1R, C2, FCGR1A, and KRT10) (Fig. 5b) and six genes (BLA-DQB, C3AR1, CFI, FCAR, FCGR3A, and LOC10498484) (Fig. 5c) enriched in the S. aureus infection pathway in the SM and SMD groups, respectively. The BLA-DQB gene encodes the bovine major histocompatibility complex, class I, DQ beta protein, which has been hypothesized to play a key role in the synchronization of the immune response to mastitis-causing bacteria in bovine udder secretory tissues [56]. Interestingly, BLA-DQB exhibited contrary directions of expression in SM and SMD compared with the healthy controls, which might be due to the differences in the duration of S. aureus infection [57], differences in age [58], parity [59] and lactation period [35] of the cattle.

The IPA analysis revealed an interaction network involving the phosphoinositide 3-kinase (PI3K) family in all three comparisons (Fig. 6, 7 and 8). The PI3K family of enzymes are involved in myriad cellular functions, including cell growth, proliferation, differentiation, motility, survival, and intracellular trafficking. In particular, PI3K proteins have important functions in immunobiology [60]. IL12 (Fig. 7 and 8) encodes an important cytokine that can regulate both innate and adaptive immune responses during infection [61]. Kinase AKT (Fig. 7 and 8) is involved in the regulation of the development and function of innate immune cells, including neutrophils, macrophages, and dendritic cells [62].

The cytokine-cytokine receptor signaling pathway genes exclusively expressed in uninfected mother-daughter pairs (EPOR, IL9, IFNL3, CCL26, and IL26) and the DEGs involved in immune-related pathways identified in the current study (including CCL20, IL13, MMP3, and BLA-DQB), may contain sequence polymorphisms that could serve as genetic markers for susceptibility to mastitis caused by S. aureus infection. Consequently, identification of SNPs within these genes and systematic evaluation through large-scale association studies using suitable animal cohorts can provide valuable information for future genome-enabled breeding programs to enhance mastitis resilience in dairy cattle.

Conclusions

In summary, the transcriptome profiles of PBL sampled from two consecutive generations of cows with naturally infected S. aureus mastitis and non-infected healthy control animals were investigated. Many of the genes highlighted in this study as being important in the bovine host response to infection with S. aureus may represent candidate PBL expression biomarkers for mastitis and may also contain sequence variation that can be leveraged for genomic selection of cattle less susceptible to mastitis disease.

Abbreviations

S. aureus

Staphylococcus aureus

S

S. aureus-infected cows

H

Healthy non-infected cows

SM

S. aureus-infected mastitis mothers

HM

Healthy non-infected mothers

SMD

S. aureus-infected daughters

HMD

Healthy non-infected daughters

EPOR

Erythropoietin receptor

IL9

Interleukin 9

IFNL3

Interferon lambda 3

CCL26

C-C motif chemokine ligand 26

IL26

Interleukin 26

DEGs

Differentially expressed genes

FDR

False discovery rate

CCL20

Chemokine (C-C motif) ligand 20

IL13

Interleukin 13

MMP3

Matrix metalloproteinase-3

IL-17

Interleukin 17

BLA-DQB

Bos taurus major histocompatibility complex, class II, QB beta

C1R

Complement C1r subcomponent

C2

Complement C2

FCGR1A

Fc fragment of IgG receptor Ia

KRT10

Keratin 10

C3AR1

Complement component 3a receptor 1

CFI

Complement factor I

FCAR

Fc fragment of IgA receptor

FCGR3A

Fc fragment of IgG, low affinity IIIa, receptor

E. coli

Escherichia coli

RNA-Seq

RNA sequencing

HTS

High-throughput sequencing

LPS

Lipopolysaccharide

PBL

Peripheral blood leukocyte

SCC

Somatic cell counts

DHI

Dairy herd improvement

Nuc

Thermonuclease

PCR

Polymerase chain reaction

RIN

RNA integrity number

GSEA

Gene set enrichment analysis

MSigDB

Molecular signature database

KEGG

Kyoto Encyclopedia of Genes and Genomes

GO

Gene ontology

IPA

Ingenuity Pathway Analysis

RT-qPCR

Reverse transcription quantitative real-time PCR

GAPDH

Glyceraldehyde-3-phosphate dehydrogenase

PI3K

Phosphoinositide 3-kinases

IL12

Interleukin 12

AKT

Protein kinase B, also known as PKB

CXCL9

Chemokine (C-X-C motif) ligand 9

SOCS1

Suppressor of cytokine signaling 1

CYP2E1

Cytochrome P450 2E1

GWAS

Genome-wide association study

TRAPPC9

Trafficking protein particle complex 9

mTORC1

Cytosolic arginine sensor for mTORC1 subunit 1

JAK2

Janus kinase 2

STAT5A

Signal transducer and activator of transcription 5A

IDO2

Indoleamine 2,3-dioxygenase 2

NR4A1

Nuclear receptor subfamily 4 group A member 1

Authors’ contributions

Ying Yu and Di Wang conceived the study. Di Wang, Lei Liu, and Tao Duan collected the samples. Di Wang, Lei Liu, and Thomas J. Hall analyzed the data. Di Wang, Lei Liu, Serafino M.A. Augustino, Tao Duan, David E. MacHugh, Jinhuan Dou, Yi Zhang, Yachun Wang, and Ying Yu wrote and prepared the manuscript. All authors reviewed and contributed to the manuscript.

Funding

This research was financially supported by the NSFC-PSF Joint Project (31961143009), Beijing Natural Science Foundation (6182021), Beijing Dairy Industry Innovation Team (BAIC06), Modern Agro-industry Technology Research System (CARS-36) and the Program for Changjiang Scholar and Innovation Research Team in University (IRT-15R62).

Availability of data and materials

All genomic annotation data defining gene regions are available for download (ftp://ftp.ensemble.org/pub/release-96/gtf/bos_taurus). RNA-Seq data from China Agricultural University is available upon the agreement of China Agricultural University and should be requested directly from the authors.

Ethics approval and consent to participate

All animal management and experimental procedures followed the animal care protocols approved by the China Agricultural University Animal Care and Use Ethics Committee.

Consent for publication

Not applicable.

Competing interests

The authors have declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s40104-020-00494-7.